Cancer treatment-induced bone loss: A review

Authors


Dr Frances Barnett, The Ludwig Institute for Cancer Research, Post Office Box 2008, Royal Melbourne Hospital, Parkville, Vic. 3050, Australia.
Email: fsbarnett@ozemail.com.au

Abstract

Cancer treatment-induced bone loss (CTIBL) is the phenomenon of loss of bone mass directly due to the effects of treatment for cancer. There are many causes of CTIBL. This article focuses on CTIBL in the hormone-dependent cancers (breast and prostate) and reviews the mechanisms, the extent of the problem and the management strategies.

Ancillary